Cargando…

A conversation with Dr. Brett Leav, Vice President of Clinical Development for Public Health Vaccines, Moderna

Detalles Bibliográficos
Autor principal: Siranosian, Kathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549574/
https://www.ncbi.nlm.nih.gov/pubmed/36285021
http://dx.doi.org/10.1017/cts.2022.443
_version_ 1784805703135789056
author Siranosian, Kathy
author_facet Siranosian, Kathy
author_sort Siranosian, Kathy
collection PubMed
description
format Online
Article
Text
id pubmed-9549574
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95495742022-10-24 A conversation with Dr. Brett Leav, Vice President of Clinical Development for Public Health Vaccines, Moderna Siranosian, Kathy J Clin Transl Sci Perspective Cambridge University Press 2022-08-19 /pmc/articles/PMC9549574/ /pubmed/36285021 http://dx.doi.org/10.1017/cts.2022.443 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspective
Siranosian, Kathy
A conversation with Dr. Brett Leav, Vice President of Clinical Development for Public Health Vaccines, Moderna
title A conversation with Dr. Brett Leav, Vice President of Clinical Development for Public Health Vaccines, Moderna
title_full A conversation with Dr. Brett Leav, Vice President of Clinical Development for Public Health Vaccines, Moderna
title_fullStr A conversation with Dr. Brett Leav, Vice President of Clinical Development for Public Health Vaccines, Moderna
title_full_unstemmed A conversation with Dr. Brett Leav, Vice President of Clinical Development for Public Health Vaccines, Moderna
title_short A conversation with Dr. Brett Leav, Vice President of Clinical Development for Public Health Vaccines, Moderna
title_sort conversation with dr. brett leav, vice president of clinical development for public health vaccines, moderna
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549574/
https://www.ncbi.nlm.nih.gov/pubmed/36285021
http://dx.doi.org/10.1017/cts.2022.443
work_keys_str_mv AT siranosiankathy aconversationwithdrbrettleavvicepresidentofclinicaldevelopmentforpublichealthvaccinesmoderna
AT siranosiankathy conversationwithdrbrettleavvicepresidentofclinicaldevelopmentforpublichealthvaccinesmoderna